These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8572847)

  • 1. Thyroid hormones and osteoporosis.
    Liel Y
    Arch Intern Med; 1996 Feb; 156(3):341. PubMed ID: 8572847
    [No Abstract]   [Full Text] [Related]  

  • 2. [The influence of thyrotoxicosis and thyroxine therapy on the risk of osteoporosis].
    Zatońska K; Bolanowski M
    Pol Merkur Lekarski; 2000 May; 8(47):356-9. PubMed ID: 10944962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormonal and biochemical parameters in postmenopausal osteoporosis].
    Dourador EB; de Falco V; Chahade WH; Cossermelli W; Yoshinari NH
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(2):60-2. PubMed ID: 9435397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.
    Sijanovic S; Karner I
    Medscape Womens Health; 2001 Oct; 6(5):3. PubMed ID: 11698925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differential osteoporosis diagnosis in the woman].
    Lippuner K; Jaeger P
    Ther Umsch; 1998 Nov; 55(11):685-95. PubMed ID: 9865145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporosis prevention and treatment: its relevance to breast cancer patients.
    Hodsman AB
    Can J Oncol; 1995 Dec; 5 Suppl 1():28-32. PubMed ID: 8853521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis.
    Shaarawy M; Zaki S; Sheiba M; El-Minawi AM
    Clin Lab; 2003; 49(11-12):625-36. PubMed ID: 14651333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiresorptive therapy for bone].
    Fortschr Med Suppl; 1997; 181():1-11. PubMed ID: 9332029
    [No Abstract]   [Full Text] [Related]  

  • 9. [Osteoporosis and nutrition].
    Burckhardt P
    Ther Umsch; 1998 Nov; 55(11):712-6. PubMed ID: 9865148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The management of thyrotoxicosis: a schematic approach].
    Papi G; Carapezzi C; Corsello SM
    Minerva Endocrinol; 2002 Jun; 27(2):119-26. PubMed ID: 11961503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ghrelin and bone mass in postmenopausal hypertensive women.
    Pérez-Castrillón JL; Justo I; Sanz A; San Miguel A; Mazón MA; Abad L; Vega G; Dueñas A
    Ann Nutr Metab; 2007; 51(3):223-7. PubMed ID: 17587793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease.
    Meier C; Meinhardt U; Greenfield JR; De Winter J; Nguyen TV; Dunstan CR; Seibel MJ
    Clin Lab; 2006; 52(1-2):1-10. PubMed ID: 16506358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone histology in postmenopausal osteoporosis--variations in cellular activity].
    Lozo P; Krpan D; Krvavica A; Vukelić Baturić T; Fistonić I; Kusec V
    Acta Med Croatica; 2004; 58(1):5-11. PubMed ID: 15125387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Osteoporosis and nutrition].
    Allolio B
    Z Arztl Fortbild (Jena); 1996 Feb; 90(1):19-24. PubMed ID: 8650958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical thyroid dysfunction.
    Woeber KA
    Arch Intern Med; 1997 May; 157(10):1065-8. PubMed ID: 9164371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postmenopausal osteoporosis: risk factors and possible therapies].
    D'Amore M; Minenna G; D'Amore S
    Minerva Med; 2003 Jun; 94(3):141-55. PubMed ID: 14605595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ipodate therapy in patients with severe destruction-induced thyrotoxicosis.
    Arem R; Munipalli B
    Arch Intern Med; 1996 Aug 12-26; 156(15):1752-7. PubMed ID: 8694676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FSH versus estrogen: who's guilty of breaking bones?
    Baron R
    Cell Metab; 2006 May; 3(5):302-5. PubMed ID: 16679287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of calcium-containing bioactive food additive in postmenopausal osteoporosis].
    Khodyrev VN; Vitilina MM; Lobanova GM
    Vopr Pitan; 2002; 71(2):33-7. PubMed ID: 12125474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
    Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ
    Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.